My oncologist emailed me.  For those of you who have been waiting with
baited breath...Bosutinib was approved today for treatment of
"previously treated" Leukemia.  It will be marketed as Bosulif.  They
saw improvement in patients previously treated with other TKI's,
although it's big claim to fame is suppose to be less severe side
effects.  Time will tell.  Can't wait to hear side effect comparisons
from those who were intolerant of the other big three.

-- 
[CMLHope]
A support group of http://cmlhope.com
-------------------------------------------------

You received this message because you are subscribed to the Google Groups 
"CMLHope" group.
To post to this group, send email to [email protected]
To unsubscribe from this group, send email to 
[email protected]
For more options, visit this group at http://groups.google.com/group/CMLHope

Reply via email to